Bio-communication device for metabolic pathway error identification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current medical approaches, both traditional and non-traditional, lack specificity in identifying and addressing acquired errors of metabolism, often leading to ineffective treatment and secondary side effects due to inadequate targeting of biochemical pathways.
Innovation Solution
A clinical method using bio-communication devices to correlate laboratory test results with a structured, sequential protocol for targeted metabolic interventions, prioritizing support for specific biochemical pathways to restore proper functioning and prevent disease progression.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional medical approaches are used to diagnose and treat chronic diseases based on symptoms, then treatment can be provided, but the underlying metabolic errors are not resolved leading to recurrence of symptoms
Solution Approach 1:
The patent segments the complex metabolic network into individual testable pathways and components. Instead of treating the body as a whole system, it divides metabolic evaluation into specific pathways (carbohydrate metabolism, lipid metabolism, protein metabolism, etc.) that can be independently assessed and treated, allowing precise identification of which specific pathway is malfunctioning
Solution Approach 2:
The patent introduces biochemical markers and intermediates as mediators to detect metabolic pathway errors. By measuring specific biochemical substances (substrates, enzymes, cofactors, metabolic intermediates) in the pathway, the system indirectly identifies the functional status of the pathway without directly observing the pathway operation itself
2Object-affected harmful factors
If pharmaceutical drugs are used to suppress symptoms, then symptom relief is achieved, but the acquired metabolic error causing the symptoms is not addressed
Solution Approach 1:
The patent converts the body's own biochemical responses and metabolic byproducts into diagnostic information. Instead of viewing biochemical markers merely as waste products or side effects of metabolism, the system uses these same biochemical substances as indicators to identify and correct the underlying metabolic errors, turning potential harmful factors into beneficial diagnostic tools
Solution Approach 2:
The patent enables the body's metabolic pathways to self-correct by providing the necessary substrates, enzymes, and cofactors that allow the pathway to function properly on its own. Rather than using external drugs to suppress symptoms, the system provides metabolic supports that enable the body's natural healing and correction mechanisms to restore proper pathway function
3Measurement precision
If comprehensive metabolic pathway analysis is implemented, then precise identification of metabolic errors is achieved, but the complexity of evaluation and treatment planning increases
Solution Approach 1:
The patent performs preliminary identification and classification of metabolic pathway errors before detailed treatment planning. By first identifying which specific pathway or component is malfunctioning through standardized testing protocols, the system prepares the foundation for targeted treatment without requiring complex real-time decision-making during treatment delivery
Solution Approach 2:
The patent applies different treatment approaches based on the specific local condition of each metabolic pathway. Instead of using a uniform treatment protocol for all metabolic disorders, the system tailors the metabolic support (specific substrates, enzymes, cofactors) to match the specific pathway defect identified, making the evaluation and treatment system more efficient despite comprehensive coverage
4Ease of operation
If metabolic supports are provided without structured protocol, then treatment can begin immediately, but the body may be overwhelmed and pathways may flood downstream pathways
Solution Approach 1:
The patent implements periodic evaluation and adjustment of metabolic support dosing. Rather than providing continuous maximum-dose metabolic supports, the system uses evaluation protocols to determine appropriate dosing intervals and adjusts the metabolic support provision over time, allowing the body to gradually adapt and process the supports without overwhelming the system
Solution Approach 2:
The patent makes the metabolic support protocol dynamic and adaptive rather than static. The evaluation results directly inform the treatment plan, which is then adjusted based on response to treatment and changes in metabolic pathway function. This dynamic approach allows the system to optimize the balance between providing adequate metabolic support and avoiding overwhelming the biochemical pathways
Data Source
AI summary
Disclosed herein are methods, devices and systems of treating dysfunctional biochemical pathway(s) using an individualized treatment plan (ITP) of metabolic support intervention(s) for a patient. The ITP has metabolic support intervention(s) that restore proper functioning of biochemical pathway(s) correcting dysfunction(s) therein. Methods can include determining if the biochemical pathway(s) are dysfunctional by subjecting, via a bio-communication device, the patient to a noninvasive test that includes simulating one or more stimuli that are indicative of the biochemical pathway(s)' s functioning. Methods can include developing the ITP by subjecting, via the bio-communication device, the patient to a noninvasive test that includes simulating metabolic support intervention(s) to identify those that support restoration of proper functioning to the biochemical pathway(s); adding those that support restoration of proper functioning to the biochemical pathway(s); and periodically revising the ITP as re-evaluation of the patient reflects the “then-current” biochemical status of the patient. Methods include implementing the ITP.